Cargando…
Evaluation of an extracorporeal ozone-based bactericide system for the treatment of Escherichia coli sepsis
BACKGROUND: Sepsis is associated with substantial mortality rates. Antibiotic treatment is crucial, but global antibiotic resistance is now classified as one of the top ten global public health risks facing humanity. Ozone (O(3)) is an inorganic molecule with no evident function in the body. We inve...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038973/ https://www.ncbi.nlm.nih.gov/pubmed/35467176 http://dx.doi.org/10.1186/s40635-022-00443-w |
_version_ | 1784694019400400896 |
---|---|
author | Skorup, Paul Fransson, Anette Gustavsson, Jenny Sjöholm, Johan Rundgren, Henrik Özenci, Volkan Wong, Alicia Y. W. Karlsson, Tomas Svensén, Christer Günther, Mattias |
author_facet | Skorup, Paul Fransson, Anette Gustavsson, Jenny Sjöholm, Johan Rundgren, Henrik Özenci, Volkan Wong, Alicia Y. W. Karlsson, Tomas Svensén, Christer Günther, Mattias |
author_sort | Skorup, Paul |
collection | PubMed |
description | BACKGROUND: Sepsis is associated with substantial mortality rates. Antibiotic treatment is crucial, but global antibiotic resistance is now classified as one of the top ten global public health risks facing humanity. Ozone (O(3)) is an inorganic molecule with no evident function in the body. We investigated the bactericide properties of ozone, using a novel system of extracorporeal ozone blood treatment. We hypothesized that ozone would decrease the concentration of viable Escherichia coli (E. coli) in human whole blood and that the system would be technically feasible and physiologically tolerable in a clinically relevant model of E. coli sepsis in swine. METHODS: The E. coli strain B09-11822, a clinical isolate from a patient with septic shock was used. The in vitro study treated E. coli infected human whole blood (n = 6) with ozone. The in vivo 3.5-h sepsis model randomized swine to E. coli infusion and ozone treatment (n = 5) or E. coli infusion and no ozone treatment (n = 5). Live E. coli, 5 × 10(7) colony-forming units (CFU/mL) was infused in a peripheral vein. Ozone treatment was initiated with a duration of 30 min after 1.5 h. RESULTS: The single pass in vitro treatment decreased E. coli by 27%, mean 1941 to 1422 CFU/mL, mean of differences − 519.0 (95% CI − 955.0 to − 82.98, P = 0.0281). pO(2) increased (95% CI 31.35 to 48.80, P = 0.0007), pCO(2) decreased (95% CI − 3.203 to − 1.134, P = 0.0069), oxyhemoglobin increased (95% CI 1.010 to 3.669, P = 0.0113). Methemoglobin was not affected. In the sepsis model, 9/10 swine survived. One swine randomized to ozone treatment died from septic shock before initiation of the treatment. Circulatory, respiratory, and metabolic parameters were not affected by the ozone treatment. E. coli in arterial blood, in organs and in aerobic and anaerobic blood cultures did not differ. Hemoglobin, leucocytes, and methemoglobin were not affected by the treatment. CONCLUSIONS: Ozone decreased the concentration of viable E. coli in human whole blood. The system was technically feasible and physiologically tolerable in porcine sepsis/septic shock and should be considered for further studies towards clinical applications. |
format | Online Article Text |
id | pubmed-9038973 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-90389732022-05-07 Evaluation of an extracorporeal ozone-based bactericide system for the treatment of Escherichia coli sepsis Skorup, Paul Fransson, Anette Gustavsson, Jenny Sjöholm, Johan Rundgren, Henrik Özenci, Volkan Wong, Alicia Y. W. Karlsson, Tomas Svensén, Christer Günther, Mattias Intensive Care Med Exp Research Articles BACKGROUND: Sepsis is associated with substantial mortality rates. Antibiotic treatment is crucial, but global antibiotic resistance is now classified as one of the top ten global public health risks facing humanity. Ozone (O(3)) is an inorganic molecule with no evident function in the body. We investigated the bactericide properties of ozone, using a novel system of extracorporeal ozone blood treatment. We hypothesized that ozone would decrease the concentration of viable Escherichia coli (E. coli) in human whole blood and that the system would be technically feasible and physiologically tolerable in a clinically relevant model of E. coli sepsis in swine. METHODS: The E. coli strain B09-11822, a clinical isolate from a patient with septic shock was used. The in vitro study treated E. coli infected human whole blood (n = 6) with ozone. The in vivo 3.5-h sepsis model randomized swine to E. coli infusion and ozone treatment (n = 5) or E. coli infusion and no ozone treatment (n = 5). Live E. coli, 5 × 10(7) colony-forming units (CFU/mL) was infused in a peripheral vein. Ozone treatment was initiated with a duration of 30 min after 1.5 h. RESULTS: The single pass in vitro treatment decreased E. coli by 27%, mean 1941 to 1422 CFU/mL, mean of differences − 519.0 (95% CI − 955.0 to − 82.98, P = 0.0281). pO(2) increased (95% CI 31.35 to 48.80, P = 0.0007), pCO(2) decreased (95% CI − 3.203 to − 1.134, P = 0.0069), oxyhemoglobin increased (95% CI 1.010 to 3.669, P = 0.0113). Methemoglobin was not affected. In the sepsis model, 9/10 swine survived. One swine randomized to ozone treatment died from septic shock before initiation of the treatment. Circulatory, respiratory, and metabolic parameters were not affected by the ozone treatment. E. coli in arterial blood, in organs and in aerobic and anaerobic blood cultures did not differ. Hemoglobin, leucocytes, and methemoglobin were not affected by the treatment. CONCLUSIONS: Ozone decreased the concentration of viable E. coli in human whole blood. The system was technically feasible and physiologically tolerable in porcine sepsis/septic shock and should be considered for further studies towards clinical applications. Springer International Publishing 2022-04-25 /pmc/articles/PMC9038973/ /pubmed/35467176 http://dx.doi.org/10.1186/s40635-022-00443-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Articles Skorup, Paul Fransson, Anette Gustavsson, Jenny Sjöholm, Johan Rundgren, Henrik Özenci, Volkan Wong, Alicia Y. W. Karlsson, Tomas Svensén, Christer Günther, Mattias Evaluation of an extracorporeal ozone-based bactericide system for the treatment of Escherichia coli sepsis |
title | Evaluation of an extracorporeal ozone-based bactericide system for the treatment of Escherichia coli sepsis |
title_full | Evaluation of an extracorporeal ozone-based bactericide system for the treatment of Escherichia coli sepsis |
title_fullStr | Evaluation of an extracorporeal ozone-based bactericide system for the treatment of Escherichia coli sepsis |
title_full_unstemmed | Evaluation of an extracorporeal ozone-based bactericide system for the treatment of Escherichia coli sepsis |
title_short | Evaluation of an extracorporeal ozone-based bactericide system for the treatment of Escherichia coli sepsis |
title_sort | evaluation of an extracorporeal ozone-based bactericide system for the treatment of escherichia coli sepsis |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038973/ https://www.ncbi.nlm.nih.gov/pubmed/35467176 http://dx.doi.org/10.1186/s40635-022-00443-w |
work_keys_str_mv | AT skoruppaul evaluationofanextracorporealozonebasedbactericidesystemforthetreatmentofescherichiacolisepsis AT franssonanette evaluationofanextracorporealozonebasedbactericidesystemforthetreatmentofescherichiacolisepsis AT gustavssonjenny evaluationofanextracorporealozonebasedbactericidesystemforthetreatmentofescherichiacolisepsis AT sjoholmjohan evaluationofanextracorporealozonebasedbactericidesystemforthetreatmentofescherichiacolisepsis AT rundgrenhenrik evaluationofanextracorporealozonebasedbactericidesystemforthetreatmentofescherichiacolisepsis AT ozencivolkan evaluationofanextracorporealozonebasedbactericidesystemforthetreatmentofescherichiacolisepsis AT wongaliciayw evaluationofanextracorporealozonebasedbactericidesystemforthetreatmentofescherichiacolisepsis AT karlssontomas evaluationofanextracorporealozonebasedbactericidesystemforthetreatmentofescherichiacolisepsis AT svensenchrister evaluationofanextracorporealozonebasedbactericidesystemforthetreatmentofescherichiacolisepsis AT gunthermattias evaluationofanextracorporealozonebasedbactericidesystemforthetreatmentofescherichiacolisepsis |